Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.
Genestra brand AFA-gen capsule 15 mg Niacin/ capsule 300 mg Recalled by Seroyal International, a division of Atrium Innovations Due to Microcystins level found to be above the specification...
What You Should Do
Stop using this product immediately. Do not consume, use, or distribute it.
Return the product to the place of purchase for a full refund. If you have questions, contact Seroyal International, a division of Atrium Innovations directly.
Affected Products
Genestra brand AFA-gen capsule 15 mg Niacin/ capsule 300 mg Blue Green Algae / capsule 2 capsules, twice daily Dietary supplement 90 capsules, White 150cc HDPE Bottle with Desiccant and white cap, packed as 12 bottles / shipper case
Quantity: 4,226 bottles (1691 Canada and 2535 USA)
Why Was This Recalled?
Microcystins level found to be above the specification limit of NMT1 ppm as per Raw Material Specification.
Where Was This Sold?
Product was distributed throughout the United States and Canada (see attached document for list of Canadian consignees).
About Seroyal International, a division of Atrium Innovations
Seroyal International, a division of Atrium Innovations has 1 total recall tracked by RecallDetector.
Related Recalls
FSIS Issues Public Health Alert for Beef and Pork Products Produced Without the Benefit of Inspection
· March 27, 2026
FSIS Issues Public Health Alert for Ground Beef Products Due to Possible Foreign Material Contamination
· March 27, 2026
FSIS Issues Public Health Alert For Frozen Ready-To-Eat Turkey Stuffed Pastry Products Due To Misbranding
· March 27, 2026
Pork Dynasty Inc. Recalls Ready-to-Eat Fried Pork Skin Products Due to Misbranding and Undeclared Allergen
Pork Dynasty Inc. · March 27, 2026
Dearborn Sausage Company, Inc. Recalls Wiener Products Due to Misbranding and Undeclared Allergens
Dearborn Sausage Company, Inc. · March 27, 2026
Data sourced from the FDA (Food). Last updated March 26, 2026. View original report